Clinical Trial Update: Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial testing a combination of tamoxifen and SUBA-itraconazole for ovarian cancer; the study is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• SUBA-Itraconazole (itraconazole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Anthony Joshua, FRACP | Conditions: Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING